"I want to make this a priority" - A doctor's perspective on Tzield

Diabetes Connections | Type 1 Diabetes · Apr 12, 2023 · 1m

Dr. Bryce Nelson is one of the first doctors in the country to administer the new Tzield to delay the onset of type 1. He's been involved with TrialNet, identifying those who have the genetic markets for T1D and says that research was exciting but frustrating because they had no treatment. Now, they're looking at a possibly new way of talking about T1D.

Dr. Nelson is the Chief of Endocrinology at Children's Hospital of Richmond at VCU

Dr. Nelson takes us through the process of using Tzield – which was researched under the name teplizumab – from identifying the patient, to treatment to what…